Methylselenocysteine preventing castration-resistant progression of prostate cancer

BACKGROUND: Castration-resistant progression of prostate cancer after androgen deprivation therapy remains a critical challenge in the clinical management of prostate cancer. Resurgent androgen receptor activity is an established driver of castration-resistant progression, and upregulation of androg...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Prostate
Main Authors: Liu, Yanbo, Liu, Xichun, Guo, Yaxiong, Liang, Zuowen, Tian, Yong, Lu, Lili, Zhao, Xiaohui, Sun, Ying, Zhao, Xuejian, Zhang, Haitao, Dong, Yan
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4424181/
https://ncbi.nlm.nih.gov/pubmed/25754033
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.22987
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki